The global insulin management system market is set for unprecedented growth, with projections showing a remarkable compound annual growth rate (CAGR) of 19% over the forecast period. The market, which held a significant revenue of USD 21.11 billion in 2022, is expected to surpass USD 120 billion by 2032. This growth is driven by the …